Abstract

Background An aberrant regulation of immunological, metabolic, vascular and endocrine processes leads to obstetric complications, including recurrent pregnancy loss (RPL) [1]. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a negative regulator of T cell activation [2] expressed in placental fibroblasts and may modulate peripheral selftolerance of the allogenic fetus [3,4]. It is a stimulatory molecule involved in T-cell activation at the maternal– fetal interface in women with unexplained pregnancy loss [5,6]. In this study, we investigate the possible associations of Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) gene polymorphisms with idiopathic recurrent pregnancy loss (RPL).

Highlights

  • An aberrant regulation of immunological, metabolic, vascular and endocrine processes leads to obstetric complications, including recurrent pregnancy loss (RPL) [1]

  • The distribution of rs231775 (P

  • Among the six three-locus Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) haplotypes constructed, increased frequency of CGA (P=0.0046), and CAG (P=0.036) haplotypes were seen in RPL cases, conferring disease susceptibility nature to these haplotypes

Read more

Summary

Background

An aberrant regulation of immunological, metabolic, vascular and endocrine processes leads to obstetric complications, including recurrent pregnancy loss (RPL) [1]. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a negative regulator of T cell activation [2] expressed in placental fibroblasts and may modulate peripheral selftolerance of the allogenic fetus [3,4]. It is a stimulatory molecule involved in T-cell activation at the maternal– fetal interface in women with unexplained pregnancy loss [5,6]. Among the six three-locus CTLA-4 haplotypes constructed (rs5742909/rs231775/rs3087243), increased frequency of CGA (P=0.0046), and CAG (P=0.036) haplotypes were seen in RPL cases, conferring disease susceptibility nature to these haplotypes

Materials and methods
Results
Baek KH
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.